A61K 47/28
Steroids
Official title: Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
A61K47/28 (Steroids) appears on 593 US grants and 1,050 published applications in this corpus.
Search patents in A61K- Granted patents
- 593
- Published applications
- 1,050
- Assignees
- 534
- Inventors
- 2,013
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 4 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 7 | 0 |
| 1993 | 4 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 1 | 0 |
| 1997 | 8 | 0 |
| 1998 | 10 | 0 |
| 1999 | 12 | 0 |
| 2000 | 3 | 0 |
| 2001 | 10 | 1 |
| 2002 | 6 | 11 |
| 2003 | 7 | 9 |
| 2004 | 1 | 12 |
| 2005 | 4 | 11 |
| 2006 | 4 | 8 |
| 2007 | 3 | 7 |
| 2008 | 3 | 14 |
| 2009 | 1 | 14 |
| 2010 | 7 | 15 |
| 2011 | 5 | 16 |
| 2012 | 5 | 21 |
| 2013 | 5 | 27 |
| 2014 | 17 | 25 |
| 2015 | 15 | 60 |
| 2016 | 22 | 45 |
| 2017 | 29 | 43 |
| 2018 | 37 | 67 |
| 2019 | 28 | 62 |
| 2020 | 38 | 67 |
| 2021 | 48 | 86 |
| 2022 | 47 | 86 |
| 2023 | 45 | 90 |
| 2024 | 40 | 107 |
| 2025 | 55 | 84 |
| 2026 | 39 | 62 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Lipid nanoparticles comprising sterols and mRNA6 Oct 2026US 12,751,999 B2eTheRNA Immunitherapies NV
- Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof6 Oct 2026US 12,753,170 B2Akagera Medicines, Inc.
- Pharmaceutical composition for controlled release of weak acid drugs and uses thereof29 Sep 2026US 12,746,200 B2Pharmosa Biopharm Inc.
- Stealth lipid nanoparticle compositions for cell targeting29 Sep 2026US 12,746,209 B2Generation Bio Co.
- Blood-brain barrier permeable heteroduplex nucleic acid29 Sep 2026US 12,746,253 B2National University Corporation Tokyo Medical and Dental University
- Liposome conjugate targeting m2 macrophage and use thereof8 Oct 2026US 2026/0306657 A1Hangzhou Normal University
- Pharmaceutical composition comprising kras g12d inhibitor1 Oct 2026US 2026/0294931 A1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Highly water-dispersible composition having high ceramide content24 Sep 2026US 2026/0283987 A1Moogene Medi Co., Ltd.
- Ionizable lipids and liposomal nanoparticle compositions24 Sep 2026US 2026/0284195 A1Akagera Medicines, Inc.
- Polymeric bile acid ester nanoparticles to induce tolerance10 Sep 2026US 2026/0263377 A1Yale University
Most cited
By later US patents
- Preparation for treatment of spinal cord injury541US 9,040,062 B2Keio University · 2015
- Engineered nucleic acids encoding a modified erythropoietin and their expression312US 8,710,200 B2Moderna Therapeutics, Inc. · 2014
- Carbohydrate conjugates as delivery agents for oligonucleotides273US 8,106,022 B2Alnylam Pharmaceuticals, Inc. · 2012
- Carbohydrate conjugates as delivery agents for oligonucleotides185US 8,828,956 B2Alnylam Pharmaceuticals, Inc. · 2014
- GLP-1 formulations180US 6,358,924 B1Eli Lilly and Company · 2002